Market Overview:
The global exosome diagnostic and therapeutic market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in exosome diagnostics. The global exosome diagnostic and therapeutic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments, reagents, and software. The instruments segment is further sub-segmented into extraction kits/devices/systems and analysis systems. The reagents segment is further sub-segmented into antibodies/proteins/enzymes and nucleic acids (DNA or RNA). The software segment includes data management tools for analyzing exosomes as well as downstream data analysis tools used for biomarker identification from exosomes. On the basis of application, the market is divided into cancer institutes, hospitals & clinics (including pathology labs), diagnostic centers (including reference labs), research institutes & universities; biotechnology & pharmaceutical companies; contract research organizations (CROs); other end users such as nutraceutical companies etc.).
Product Definition:
Exosomes are small vesicles released by cells that can mediate cell-to-cell communication and carry cargo such as proteins, lipids and nucleic acids. Exosomes have been proposed as a new class of biomarkers for cancer diagnosis and prognosis, and also present potential therapeutic targets.
Instrument:
Instruments are devices or machines that help in collecting, analyzing and presenting data for research purpose. It can be broadly segmented into two categories, one is analytical and other is therapeutic. Analytical segment includes instruments used for measuring specific properties of molecules such as size, shape and chemical composition while therapeutic category consists of devices used for treatment or therapy.
Reagent:
Reagents are chemicals that help in enhancing or detecting a specific property of a biological specimen. In the case of molecular biology, reagents are used to detect and purify DNA, RNA, Proteins etc. The most commonly used reagent is PCR (polymerase chain reaction) which helps in amplifying a specific region from an initial sample to exponential levels for further analysis.
Application Insights:
The cancer institute segment dominated the global exosome diagnostic and therapeutic market in 2017. This can be attributed to factors such as increasing government funding for cancer research, growing awareness about advanced treatment options, and rising prevalence of the disease. For instance, according to the American Cancer Society there were an estimated 210,480 new cases of invasive breast carcinoma diagnosed in women across the globe in 2018. Therefore, demand for early diagnosis is expected to increase over time which will drive growth during forecast period.
On other hand, hospital-based diagnostics are anticipated to witness lucrative growth during forecast period owing to factors such as increasing number of patients with chronic diseases like Parkinson¢â‚¬â„¢s disease or multiple sclerosis who require long term care & higher reimbursement rates by insurance companies for these diseases coupled with technological advancements that enhance accuracy of tests performed at hospitals & healthcare centers.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, increasing prevalence of cancer, and availability of reimbursement facilities for diagnostic procedures. The U.S.-based companies are engaged in extensive research activities to develop novel reagents and assays for use across different disease areas including oncology and infectious diseases such as HIV/AIDS, malaria & dengue fever etc.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as rapidly improving healthcare infrastructure with an increase in government spending on medical research coupled with rising awareness about early diagnosis leading towards higher adoption rates for exosome-based diagnostics & therapeutics among patients throughout this region will drive growth over next eight years.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in exosome isolation and analysis techniques
- Growing investment in research and development of exosome-based diagnostics and therapeutics
- increasing number of collaborations and partnerships between pharmaceutical companies, biotechnology firms, and academic institutions
Scope Of The Report
Report Attributes
Report Details
Report Title
Exosome Diagnostic and Therapeutic Market Research Report
By Type
Instrument, Reagent, Software
By Application
Cancer Institute, Hospital, Diagnostic Center, Others
By Companies
AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Exosome Diagnostic and Therapeutic Market Report Segments:
The global Exosome Diagnostic and Therapeutic market is segmented on the basis of:
Types
Instrument, Reagent, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Institute, Hospital, Diagnostic Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AMS Biotechnology
- ReNeuron
- ExoCyte Therapeutics
- Cell Guidance Systems
- BioRegenerative Sciences
- Norgen Biotek
- ...
Highlights of The Exosome Diagnostic and Therapeutic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instrument
- Reagent
- Software
- By Application:
- Cancer Institute
- Hospital
- Diagnostic Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Exosome Diagnostic and Therapeutic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Exosomes are small vesicles that are released by cells and play an important role in cell-to-cell communication. They can be used to diagnose and treat diseases.
Some of the key players operating in the exosome diagnostic and therapeutic market are AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences, Norgen Biotek.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Exosome Diagnostic and Therapeutic Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Exosome Diagnostic and Therapeutic Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Exosome Diagnostic and Therapeutic Market - Supply Chain
4.5. Global Exosome Diagnostic and Therapeutic Market Forecast
4.5.1. Exosome Diagnostic and Therapeutic Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Exosome Diagnostic and Therapeutic Market Size (000 Units) and Y-o-Y Growth
4.5.3. Exosome Diagnostic and Therapeutic Market Absolute $ Opportunity
5. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
5.3.1. Instrument
5.3.2. Reagent
5.3.3. Software
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
6.3.1. Cancer Institute
6.3.2. Hospital
6.3.3. Diagnostic Center
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Exosome Diagnostic and Therapeutic Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029
9. North America Exosome Diagnostic and Therapeutic Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
9.4.1. Cancer Institute
9.4.2. Hospital
9.4.3. Diagnostic Center
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
9.7.1. Instrument
9.7.2. Reagent
9.7.3. Software
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029
10. Latin America Exosome Diagnostic and Therapeutic Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
10.4.1. Cancer Institute
10.4.2. Hospital
10.4.3. Diagnostic Center
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
10.7.1. Instrument
10.7.2. Reagent
10.7.3. Software
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Exosome Diagnostic and Therapeutic Demand Share Forecast, 2019-2029
11. Europe Exosome Diagnostic and Therapeutic Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
11.4.1. Cancer Institute
11.4.2. Hospital
11.4.3. Diagnostic Center
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
11.7.1. Instrument
11.7.2. Reagent
11.7.3. Software
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Exosome Diagnostic and Therapeutic Demand Share, 2019-2029
12. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
12.4.1. Cancer Institute
12.4.2. Hospital
12.4.3. Diagnostic Center
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
12.7.1. Instrument
12.7.2. Reagent
12.7.3. Software
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Exosome Diagnostic and Therapeutic Demand Share, 2019-2029
13. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Application
13.4.1. Cancer Institute
13.4.2. Hospital
13.4.3. Diagnostic Center
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size and Volume Forecast by Type
13.7.1. Instrument
13.7.2. Reagent
13.7.3. Software
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Exosome Diagnostic and Therapeutic Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Exosome Diagnostic and Therapeutic Market: Market Share Analysis
14.2. Exosome Diagnostic and Therapeutic Distributors and Customers
14.3. Exosome Diagnostic and Therapeutic Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AMS Biotechnology
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ReNeuron
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ExoCyte Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cell Guidance Systems
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioRegenerative Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Norgen Biotek
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ...
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
